<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="73803">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01822743</url>
  </required_header>
  <id_info>
    <org_study_id>P111007</org_study_id>
    <nct_id>NCT01822743</nct_id>
  </id_info>
  <brief_title>Osteopathy and Obstructive Sleep Apnea Syndrome II</brief_title>
  <acronym>OSTEOSAOSII</acronym>
  <official_title>A Single Blind Cross Over Trial to Compare Osteopathic Compression of Pterygopalatine Node to Sham in Patients With Obstructive Sleep Apnea Syndrome and in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to evaluate an osteopathic compression of pterygopalatine node in
      healthy subjects and patients suffering from obstructive apnea syndrome (OSA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Osteopathic compression will be compared to a sham manoeuvre in a cross over design on apnea
      hypopnea index, pharyngeal collapsibility and symptoms in patients suffering from OSA, and
      on symptoms and pharyngeal collapsibility in healthy subjects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Apnea-hypopnea index</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pharyngeal sensitivity test</measure>
    <time_frame>30 min</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of pharyngeal critical pressure</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily clinical symptoms of osa</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pharyngeal sensitivity test</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of pharyngeal critical pressure</measure>
    <time_frame>30 min</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inspiratory nasal pic flow</measure>
    <time_frame>30 min</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inspiratory nasal pic flow</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>Osteopathic manipulative treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Osteopathic compression of pterygopalatine node</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham comparator</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham Osteopathic pterygopalatine node compression</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Osteopathic manipulative treatment</intervention_name>
    <description>Osteopathic compression of pterygopalatine node</description>
    <arm_group_label>Osteopathic manipulative treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sham comparator</intervention_name>
    <arm_group_label>Sham comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Obstructive sleep apnea syndrome patient:

        Inclusion criteria :

          -  Male or Female aged 18 years or more

          -  Obstructive sleep apnea syndrome with apnea/hypopnea index &gt; or = 15/hour

          -  Body mass Index &lt;40kg/m2

        Exclusion criteria :

          -  Pregnant or lactating women

          -  Participating to another trial

          -  Acute infectious disease of upper respiratory airway tract at inclusion

          -  Complete nasal obstruction

          -  Facial neuralgia at inclusion

          -  Patients not able to stop treatment for OSA within one week before each visit

          -  Allergy to latex

          -  Dental extraction within 15 days before inclusion

          -  Pharyngeal surgery in the past

          -  Incapable adult

          -  Patients treated with Selective Serotonin Reuptake Inhibitor

        Healthy Volunteers

        Inclusion criteria :

          -  Male or Female aged ≥18 and  ≤ 40 years

          -  No obstructive sleep apnea syndrome

          -  Body mass Index &lt;30kg/m2

          -  No chronicle respiratory, neurological, cardiac or able to deteriorate sleep quality
             disease

          -  Low obstructive sleep apnea syndrome probability measured with Berlin Scale

        Exclusion criteria :

          -  Pregnant or lactating women

          -  Participating to another trial

          -  Acute infectious disease of upper respiratory airway tract at inclusion

          -  Complete nasal obstruction

          -  Facial neuralgia at inclusion

          -  allergy to latex

          -  dental extraction within 15 days before inclusion

          -  pharyngeal surgery in the past

          -  incapable adult

          -  patients treated background treatment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valérie Attali, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service des pathologies du sommeil, Pitié-Salpêtrière hospital</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie Attali, MD</last_name>
      <phone>+ 33 1 42 16 77 23</phone>
      <email>valerie.attali@psl.aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Similowski, MD, PhD</last_name>
      <phone>+ 33 1 42 16 77 52</phone>
      <email>thomas.similowski@psl.aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Valérie Attali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 12, 2013</lastchanged_date>
  <firstreceived_date>March 28, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteopathy</keyword>
  <keyword>Sleep Apnea Syndromes</keyword>
  <keyword>Obstructive Sleep Apnea</keyword>
  <keyword>Pcrit</keyword>
  <keyword>Polysomnography</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
